Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Other financing activities: 2009-2024

Historic Other financing activities for Cytokinetics (CYTK) over the last 15 years, with Dec 2024 value amounting to $19.6 million.

  • Cytokinetics' Other financing activities was N/A to $720,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year change of. This contributed to the annual value of $19.6 million for FY2024, which is 86.66% up from last year.
  • As of FY2024, Cytokinetics' Other financing activities stood at $19.6 million, which was up 86.66% from $10.5 million recorded in FY2023.
  • In the past 5 years, Cytokinetics' Other financing activities ranged from a high of $19.6 million in FY2024 and a low of $2.3 million during FY2020.
  • Its 3-year average for Other financing activities is $13.2 million, with a median of $10.5 million in 2023.
  • Data for Cytokinetics' Other financing activities shows a peak YoY skyrocketed of 208.06% (in 2020) over the last 5 years.
  • Over the past 5 years, Cytokinetics' Other financing activities (Yearly) stood at $2.3 million in 2020, then surged by 97.29% to $4.4 million in 2021, then surged by 115.82% to $9.6 million in 2022, then increased by 9.53% to $10.5 million in 2023, then surged by 86.66% to $19.6 million in 2024.